HCWB — HCW Biologics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates HCWB Bearish with a Setup Score of 0, net conviction 32, actionability 0. How the Setup Score works →

Total Setup Score0
Directional BiasBearish
Net Conviction32
Actionability0 (no mans land)

Key signals behind this score

About HCW Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which … Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$4.30
Market Cap$6.9M
Float975K
Shares Outstanding1.6M
Price/Sales (TTM)1.04
vs. Analyst Target+597.7% to analyst PT
Profit Margin-34.74%
Operating Margin (TTM)49.45%
Revenue (TTM)$6.6M
Dividend RateNone
Analyst Target Price$30.00 (1 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $4.1M -$5.8M $4.1M -$5.3M
2021 $4.1M -$12.9M -$543,598 -$12.3M
2022 $6.7M -$14.9M $2.6M -$14.1M
2023 $2.8M -$25.0M $560,360 -$23.6M
2024 $2.6M -$30.0M $959,403 -$27.7M
2025 $54,232 -$8.0M $10,846 -$5.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $6,550 -$1.9M
Sep 2025 $15,606 -$4.6M
Dec 2025 $27,010 $719,232
Mar 2026 $6.5M $4.1M

Ownership & Float

Insider Ownership9.2%
Institutional Ownership8.6%
Short Float30.4%

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.62Near-term / short-term trend
Weekly40-Week SMA$1.65Medium-term trend
Weekly80-Week SMA$5.28Cyclical trend (business cycle)
Weekly200-Week SMA$36.94Secular trend (multi-year)
Monthly10-Month SMA$2.07Near-term monthly trend
Monthly20-Month SMA$5.48Medium-term monthly trend
Monthly40-Month SMA$27.54Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$0.50 support 5.20x 1 months ago
$5.60 resistance 1.50x 9 months ago
$43.00 resistance 1.76x 24 months ago

Historical Earnings Reactions

TimeframeAvg ReturnMedianWin RateBestWorst
Gap N/A N/A N/A N/A N/A
1 Day N/A N/A N/A N/A N/A
1 Week N/A N/A N/A N/A N/A
2 Weeks N/A N/A N/A N/A N/A
1 Month N/A N/A N/A N/A N/A

Next earnings: August 17, 2026 (44 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 1.27% 36.5% 230
Tuesday 0.64% 37.4% 257
Wednesday -0.33% 42.6% 256
Thursday -0.61% 38.7% 248
Friday 1.37% 43.6% 250

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 8.6%

Insider Transactions — Smart Summary

Total insider ownership: 9.2%

12-Month Insider Activity Summary

Total Filings3
Net Value+$180,000.17
Net Shares Change306,050
% of Float31.4%
C-Suite Filings2
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
GARRETT SCOTT T +$250,000.08 1 1 buy
Wong Hing C Chief Executive Officer +$159,999.995 1 1 buy
Byam Rebecca Chief Financial Officer +$20,000.175 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-05-27 – 2026-05-27 3 3 +$430,000.25 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-27 Wong Hing C Chief Executive Officer +$159,999.995 Transaction at $1.41, now +206.0%
2026-05-27 Byam Rebecca Chief Financial Officer +$20,000.175 Transaction at $1.41, now +206.0%
2026-05-27 GARRETT SCOTT T +$250,000.08 Transaction at $1.41, now +206.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for HCW Biologics Inc (HCWB) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for HCWB on Trend Edge →